Search for: "MERRELL v. U.S."
Results 221 - 240
of 382
Sorted by Relevance
|
Sort by Date
3 Jul 2012, 8:10 am
Merrell Dow Pharms., 509 U.S. 579 (1993)). [read post]
22 Jun 2012, 11:41 am
Merrell Dow Pharm., Inc., 509 U.S. 579 (1993). [read post]
30 Jan 2011, 5:29 pm
U.S. ex rel. [read post]
5 Jun 2013, 5:29 am
Oct. 24, 1996) Merrell Dow Pharms., Inc. v. [read post]
31 Mar 2016, 8:09 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), nor did Tyson offer a rebuttal expert witness. [read post]
20 Sep 2021, 11:20 am
Merrell Dow Pharmaceuticals. [read post]
18 May 2011, 4:08 pm
Merrell Dow Pharmaceuticals, 509 U.S. 579 [1993]) to determine whether expert scientific testimony is admissible. [read post]
6 Apr 2021, 2:30 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
30 May 2017, 10:10 am
Merrell Dow Pharmaceuticals Inc. [read post]
28 Aug 2022, 5:54 am
The U.S. [read post]
5 Nov 2008, 8:48 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993)] analysis. [read post]
12 Feb 2020, 5:29 pm
Merrell Dow Pharmaceuticals. [read post]
20 Dec 2017, 12:00 am
Merrell Dow Pharmaceuticals, Inc. [read post]
13 Apr 2007, 8:09 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and Frye v. [read post]
15 May 2014, 9:36 am
” Rosen v. [read post]
28 Jun 2012, 5:52 am
Levinson, 485 U.S. 224 (1988). [read post]
20 Sep 2011, 1:45 pm
Merrell Dow Pharms., Inc., 509 U.S. 579 (1993), should apply at the class certification stage, but found that the district court improperly confused or diluted that standard when applying it to the plaintiffs' expert. [read post]
28 Jun 2012, 5:52 am
Levinson, 485 U.S. 224 (1988). [read post]
3 Feb 2012, 12:12 am
Merrell Dow Pharms., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993) ( “Daubert hearing”) was necessary to test the admissibility of Professor Barkun’s testimony. [read post]
10 Sep 2007, 3:47 pm
Merrell Dow Pharm., 509 U.S. 579 (1993) Popper, Conjectures and Refutations (5th ed. 1989) Neil Feigenson, Brain Imaging and Courtroom Evidence (2006). [read post]
